secwatch.observer — SEC 8-K summary
======================================

Issuer:     PepGen Inc. (PEPG)
CIK:        0001835597
Form:       8-K
Filed at:   2022-09-22T23:59:59+00:00
Accession:  0000950170-22-018744
Event type: leadership
Sentiment:  positive
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PepGen appoints former Acceleron CEO Habib Dable to Board of Directors
----------------------------------------------------------------------

- Habib Dable appointed to fill newly created Board vacancy, effective September 20, 2022.
- Dable previously led Acceleron (CEO) through blockbuster launch and $11B sale to Merck in 2021.
- Initial option award of 22,686 shares vesting over 4 years; annual cash retainers of $35,000 (Board) and $4,000 (committee).
- Dable brings 30 years' biotech and pharma experience; also serves on Blueprint Medicines and Albireo boards.
- Appointment supports PepGen's clinical development of PGN-EDO51 for Duchenne muscular dystrophy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835597/000095017022018744/0000950170-22-018744-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835597/000095017022018744/pepg-20220920.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-018744

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer